FDA, CMS Host Closed-door Clinical AI Demo Day — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- FDA and CMS officials hosted a closed-door "clinical AI demo day" on July 8 at FDA's White Oak headquarters, convening 10 health AI companies as part of efforts to safely boost clinical AI adoption.
- Anthropic, Microsoft AI, and Amazon One Medical attended alongside startups Counsel Health, Curai, K Health, Doctronic, Ellipsis Health, Hippocratic AI, and Welldoc, according to an agenda reviewed by STAT.
- Andreessen Horowitz and Khosla Ventures — both named as funders of attending startups — were represented in the room, with the event framed as a significant opportunity to help shape health AI policy and reimbursement rules.
- STAT spoke with four attendees — Counsel Health, K Health, Hippocratic AI, and Ellipsis Health — whose leaders summarized their comments to regulators after the closed-door session.
- The closed-door format was meant to give federal health officials firsthand experience with AI doctor technology as it exists today, as officials wrestle with regulating health AI and determining how to pay for it.
Why it matters: The FDA and CMS gave 10 companies — including tech giants and VC-backed startups — direct, closed-door access to shape how the government defines safe, reimbursable clinical AI, concentrating influence among those who got a seat at the table.
Ask SkimNews
